Repeated measures analysis of opioid use disorder treatment on clinical opiate withdrawal scale in a randomized clinical trial: sex differences
PsiquiatriaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Journal of addictive diseases
- Publicado em
- 19 jan 2023
- Citações
- 5
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Repeated measures analysis of opioid use disorder treatment on clinical opiate withdrawal scale in a randomized clinical trial: sex differences
Kesheng Wang, Saima Shafique, Danqing Xiao, Suzy Mascaro Walter, Ying Liu, Ubolrat Piamjariyakul, Changchun Xie
Descritores MeSH
- Opioid-Related Disorders
- Buprenorphine
- Substance Withdrawal Syndrome
- Major Depressive Disorder
- Methadone
- Naloxone
- Narcotic Antagonists
- Sex Characteristics
- Buprenorphine, Naloxone Drug Combination
- Opiate Substitution Treatment
Veja também
Estudos relacionados
- Sex-based effectiveness in buprenorphine/naloxone and methadone treatment for opioid use disorder: Findings from the OPTIMA trial
- Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: Findings from a pragmatic, pan-Canadian, randomized control trial
- Associations of Methadone and BUP/NX Dose Titration Patterns With Retention in Treatment and Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: Secondary Analysis of the OPTIMA Study
- Differential effect of cannabis use on opioid agonist treatment outcomes: Exploratory analyses from the OPTIMA study